(Oxiran-2-yl)methyl 3-nitrobenzene-1-sulfonate → HCID 17810512, compound
Reaction equation
[C:1]1([C:7]2[N:11]=[C:10]([N:12]3[CH2:17][CH2:16][NH:15][CH2:14][CH2:13]3)[S:9][N:8]=2)[CH:6]=[CH:5][CH:4]=[CH:3][CH:2]=1.[O:18]1[CH2:20][CH:19]1[CH2:21]OS(C1C=CC=C([N+]([O-])=O)C=1)(=O)=O>>[O:18]1[CH2:20][CH:19]1[CH2:21][N:15]1[CH2:16][CH2:17][N:12]([C:10]2[S:9][N:8]=[C:7]([C:1]3[CH:2]=[CH:3][CH:4]=[CH:5][CH:6]=3)[N:11]=2)[CH2:13][CH2:14]1Participants
3
Procedure
The same method as employed in the preparation of Intermediate 1 but starting from 1-(3-phenyl-1,2,4-thiadiazol-5-yl)-piperazine and 3-nitro-benzenesulfonic acid oxiranylmethyl ester gives after Biotage chromatography the title compound as a white powder in a 60% yield.
Sources & evidence
- ORD record
- ord-816d4d57629f4c22a5eed0972f6a846d
- Source dataset
- uspto-grants-2011_11
- Patent number
- US08053436B1
Reaction notes
Loading…